Changes

Jump to navigation Jump to search
72 bytes added ,  13:52, 2 August 2022
no edit summary
Line 1: Line 1: −
* Currently there are only three medications approved by the US Food and Drug Administration (FDA) for use via the intrathecal route, ie, morphine, ziconotide (best for neuropathic pain, but has narrow therapeutic window), and baclofen (for spasticity).
+
* Currently there are only three medications approved by the US Food and Drug Administration (FDA) for use via the intrathecal route:
 +
** [[Opioids|Morphine]]
 +
** Ziconotide (best for neuropathic pain, but has narrow therapeutic window)
 +
** [[Muscle Relaxants|Baclofen]] (for spasticity)
 +
* Trials should be infusions, not bolus.

Navigation menu